Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/62562
Type: Thesis
Title: Statin mediated vasodilation in the vasculature.
Author: Copley, Scott Daniel
Issue Date: 2011
School/Discipline: School of Medical Sciences
Abstract: Clinical trials have established the efficacy and safety of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) in lowering cardiovascular morbidity and mortality in patients with and without coronary artery disease. Traditionally, the beneficial effects of statins have been ascribed entirely to their ability to lower serum cholesterol. Evidence indicates, however, that statins may exert cholesterol-independent or “pleiotropic” effects. Statins may modulate vascular reactivity via the inhibition the RhoA/Rho-kinase pathway in both the vascular endothelium and the underlying vascular smooth muscle. To examine this hypothesis, we coupled the measurement of isometric force in isolated rat caudal artery segments with molecular analysis of the downstream targets of Rho-kinase in both the endothelium and smooth muscle. We report that clinical concentrations of pravastatin inhibit α₁-adrenoreceptor mediated vascular contraction through an endothelial-dependent mechanism. Our results suggest that this is mediated by an increase in P[Ser1177]eNOS phosphorylation, consistent with increased eNOS activation, increased nitric oxide production and the inhibition of the RhoA/Rho-kinase pathway in the vascular endothelium. In the context of ThromboxaneA₂ (TxA₂) receptor-mediated contraction we report that acute high dose simvastatin administration causes a robust reduction in contraction. We describe a concomitant increase eNOS Ser1177 phosphorylation, suggesting activation of eNOS and increased NO production, however, experiments in which eNOS was inhibited suggest that this mechanism does not account for the majority of relaxation. Perhaps more importantly, we report the increased activation of smooth muscle myosin phosphatase that may account for simvastatin-mediated relaxation in this preparation. Extending these results to a chronic setting we examined the consequence of 7-day statin administration on rats. Using non-invasive tail cuff we demonstrate reductions in the systolic blood pressure of healthy rats treated with clinically relevant doses of simvastatin for 7 days. Using a perfused isolated heart model we report reduced TxA₂-receptor mediated coronary perfusion pressure in hearts isolated from these animals and a reduction in TxA₂-receptor mediated contraction in isolated blood vessels. Western blot analysis revealed an increase in the expression of endothelial nitric oxide synthase (eNOS) that was concomitant with these effects. Additional administration of high dose simvastatin further reduced TxA₂-receptor mediated contraction via disinhibition of smooth muscle myosin phosphatase. These results suggest that statins may be a viable treatment option to effect acute vasodilatation in patients with normal cholesterol levels but with abnormal vasomotor reactivity and/or endothelial dysfunction.
Advisor: Wilson, David Peter Murray
Beltrame, John Francis
Dissertation Note: Thesis (Ph.D.) -- University of Adelaide, School of Medical Sciences, 2011
Keywords: statin; vasodilation; smooth muscle
Provenance: Copyright material removed from digital thesis. See print copy in University of Adelaide Library for full text.
Appears in Collections:Research Theses

Files in This Item:
File Description SizeFormat 
01front.pdf81.8 kBAdobe PDFView/Open
02whole.pdf2.36 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.